In March 2025, the company introduced new ideas for a direct-to-client giving of its Wegovy weight loss drug. The company set up a completely new pharmacy, named NovoCare, which would charge consumers $499 per 30 days for entry to the drug, lower than fifty percent the expense of the drug by mea